ProNAi Therapeutics Raises $59.5M Series D Round for Phase II Clinical Trials
Summary
ProNAi Therapeutics secured a $59.5 million Series D financing round. The company plans to use the capital to support Phase II clinical trials. This is a life sciences company event rather than a software product announcement. The funding may strengthen its ability to invest in clinical development and related operational systems.
Funding
Amount
$59.5M
Total raised
Date
April 24, 2014
Announcement date
Investors
-
Lead investors
Company
pronai.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected